H.A.P. Pols

4.6k total citations · 1 hit paper
39 papers, 3.4k citations indexed

About

H.A.P. Pols is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, H.A.P. Pols has authored 39 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Orthopedics and Sports Medicine, 13 papers in Oncology and 8 papers in Surgery. Recurrent topics in H.A.P. Pols's work include Bone health and osteoporosis research (21 papers), Bone health and treatments (12 papers) and Estrogen and related hormone effects (4 papers). H.A.P. Pols is often cited by papers focused on Bone health and osteoporosis research (21 papers), Bone health and treatments (12 papers) and Estrogen and related hormone effects (4 papers). H.A.P. Pols collaborates with scholars based in Netherlands, France and United Kingdom. H.A.P. Pols's co-authors include Albert Hofman, Chris De Laet, Johannes P.T.M. van Leeuwen, J. Reeve, Alan J. Silman, Huibert Burger, Patrick Garnero, Saeko Fujiwara, Heikki Kröger and Pierre Delmas and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

H.A.P. Pols

37 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Body mass index as a predictor of fracture risk: A meta-analysis

2005 1.2k citations Chris De Laet, H.A.P. Pols et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.A.P. Pols Netherlands	20	2.0k	889	810	799	484	39	3.4k
C Ribot France	30	2.6k 1.3×	1.1k 1.3×	964 1.2×	772 1.0×	669 1.4×	92	4.1k
B. Lund Denmark	26	2.0k 1.0×	1.2k 1.4×	1.0k 1.3×	650 0.8×	327 0.7×	72	3.8k
Jean C. Scott United States	18	2.0k 1.0×	1.3k 1.4×	674 0.8×	499 0.6×	289 0.6×	28	3.2k
Pauline M. Camacho United States	27	2.4k 1.2×	1.1k 1.3×	1.3k 1.7×	1.1k 1.4×	326 0.7×	74	4.3k
René Rizzoli Switzerland	31	2.4k 1.2×	1.1k 1.2×	1.0k 1.3×	1.1k 1.4×	946 2.0×	78	4.7k
George Wells Canada	25	1.9k 0.9×	776 0.9×	1.1k 1.3×	717 0.9×	192 0.4×	37	3.5k
Diane L. Schneider United States	18	1.9k 0.9×	1.1k 1.2×	779 1.0×	604 0.8×	240 0.5×	34	3.0k
Sophie A. Jamal Canada	37	2.9k 1.5×	1.0k 1.2×	1.6k 2.0×	905 1.1×	457 0.9×	76	5.5k
Susan Randall United States	13	3.0k 1.5×	1.5k 1.6×	1.2k 1.5×	1.2k 1.5×	485 1.0×	16	4.6k
Terrence Diamond Australia	31	1.5k 0.7×	1.2k 1.3×	1.0k 1.3×	617 0.8×	320 0.7×	89	4.1k

Countries citing papers authored by H.A.P. Pols

Since Specialization

Citations

This map shows the geographic impact of H.A.P. Pols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A.P. Pols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A.P. Pols more than expected).

Fields of papers citing papers by H.A.P. Pols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.A.P. Pols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A.P. Pols. The network helps show where H.A.P. Pols may publish in the future.

Co-authorship network of co-authors of H.A.P. Pols

This figure shows the co-authorship network connecting the top 25 collaborators of H.A.P. Pols. A scholar is included among the top collaborators of H.A.P. Pols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A.P. Pols. H.A.P. Pols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castaño‐Betancourt, Martha C., Ling Oei, Fernando Rivadeneira, et al.. (2013). Association of lumbar disc degeneration with osteoporotic fractures; the Rotterdam study and meta-analysis from systematic review. Bone. 57(1). 284–289. 34 indexed citations

Seibel, Markus J., David J. Baylink, Jonathan Farley, et al.. (2009). Basic science and clinical utility of biochemical markers of bone turnover — A congress report^*. Experimental and Clinical Endocrinology & Diabetes. 105(3). 125–133. 2 indexed citations

Essink‐Bot, Marie‐Louise, et al.. (2008). Patients' preferences for osteoporosis drug treatment: A discrete choice experiment. 1 indexed citations

Schiphof, D., Bianca M. Boxma‐de Klerk, J.H. Waarsing, et al.. (2008). 385 IDENTIFICATION OF PRE-CLINICAL OSTEOARTHRITIS: A SUBCOHORT IN THE ROTTERDAM STUDY. Osteoarthritis and Cartilage. 16. S166–S166. 1 indexed citations

Pols, H.A.P., et al.. (2007). Performance of self-assessment risk indices for encouraging appropriate use of bone density measurements among postmenopausal women.. Document Server@UHasselt (UHasselt).

Dahaghin, S, Sita Bierma‐Zeinstra, Bart W. Koes, J. M. W. Hazes, & H.A.P. Pols. (2007). Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Annals of the Rheumatic Diseases. 66(7). 916–920. 151 indexed citations

Staa, Tjeerd van, Piet Geusens, H.A.P. Pols, et al.. (2005). A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 98(3). 191–198. 116 indexed citations

Ziere, Gijsbertus, J. Dieleman, Albert Hofman, et al.. (2005). Polypharmacy and falls in the middle age and elderly population. British Journal of Clinical Pharmacology. 61(2). 218–223. 320 indexed citations

Kann, Peter Herbert, Arjan P. Bergink, Yue Fang, et al.. (2002). The Collagen Ia1 SP1 Polymorphism is Associated With Differences in Ultrasound Transmission Velocity in the Calcaneus in Postmenopausal Women. Calcified Tissue International. 70(6). 450–456. 13 indexed citations

10.

Pols, H.A.P., Richard Eastell, Pierre Delmas, et al.. (2001). Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 2 indexed citations

11.

Pols, H.A.P., et al.. (2000). Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs. Current Pharmaceutical Design. 6(7). 717–732. 59 indexed citations

12.

Delmas, PD, Steven A. Harris, H.A.P. Pols, et al.. (1999). Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women. Open Repository and Bibliography (University of Liège). 2 indexed citations

13.

Stolk, Ronald P., et al.. (1996). Hyperinsulinemia and bone mineral density in an elderly population. Bone. 18(5). 545–549. 7 indexed citations

14.

Stolk, Ronald P., Paul Van Daele, H.A.P. Pols, et al.. (1996). Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam study. Bone. 18(6). 545–549. 159 indexed citations

15.

Daele, Paul Van, Markus J. Seibel, H Burger, et al.. (1996). Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study: Table 1. BMJ. 312(7029). 482–483. 155 indexed citations

16.

Erdtsieck, Ronald J., et al.. (1995). Treatment of post‐menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial. Clinical Endocrinology. 43(5). 557–565. 35 indexed citations

17.

Birkenhäger-Frenkel, D.H., H.A.P. Pols, Rachel Schot, et al.. (1995). Effects of 24r,25-dihydroxyvitamin D3 in combination with 1α-hydroxyvitamin D3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous bone. Journal of Bone and Mineral Research. 10(2). 197–204. 25 indexed citations

18.

Daele, Paul Van, J.C. Birkenhäger, & H.A.P. Pols. (1994). Biochemical markers of bone turnover: an update.. PubMed. 44(2). 65–72. 14 indexed citations

19.

Birkenhäger, J.C., et al.. (1992). Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?. Bone and Mineral. 18(3). 251–265. 17 indexed citations

20.

Birkenhäger-Frenkel, D.H., et al.. (1989). Effects of 1α-hydroxyvitamin D3 on various stages of predialysis renal bone disease. Bone and Mineral. 6(3). 311–322. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact